🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2026-525625-21-00
Completed Phase I

A clinical trial of MK-6050 in healthy participants (MK-6050-002)

2026-525625-21-00 · tracked via the Priya Life Science EU tracker
Sponsor
Merck Sharp & Dohme LLC
Sponsor type
Pharmaceutical company
Therapeutic area
Immune System Diseases
Decision date
13/04/2026
Enrollment target
52
Sites
Belgium

Condition studied

Hidradenitis suppurativa

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2026-525625-21-00 on CTIS ↗ ← All trials in the EU